IONS
Ionis Pharmaceuticals Inc
NASDAQ: IONS · HEALTHCARE · BIOTECHNOLOGY
$74.76
-0.09% today
Updated 2026-04-30
Market cap
$11.85B
P/E ratio
—
P/S ratio
12.56x
EPS (TTM)
$-2.38
Dividend yield
—
52W range
$30 – $87
Volume
2.2M
Ionis Pharmaceuticals Inc (IONS) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$74.76
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$154.06
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.8B | $0.6B | $0.8B | $0.7B | $0.9B | $1.0B | $1.0B | $1.1B | $1.2B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 5.30% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -40.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.